BARINTHUS BIOTHERAPEUTICS PLC

Analyst Reco. Barinthus Biotherapeutics plc

Equities

BRNS

US91864C1071

Market Closed - Nasdaq Other stock markets 21:30:01 03/05/2024 BST			5-day change	1st Jan Change
2.18 ^USD	+1.63%		-12.80%	-40.92%

05-01	Barinthus Biotherapeutics plc Appoints Leon Hooftman as Chief Medical Officer, Effective from Beginning of June 2024	CI
04-18	Barinthus Cervical Lesions Treatment Study Meets Primary Objective -- Shares Rise After Hours	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vaccitech Shares Rise After Alliance Global Partners Begins Coverage With Buy Rating	25/09/23	MT
Alliance Global Partners Initiates Coverage on Vaccitech with Buy Rating, $12 Price Target	25/09/23	MT
Morgan Stanley Downgrades Vaccitech to Equal Weight From Overweight, Cuts Price Target to $3.25 From $14	25/09/23	MT
Morgan Stanley Adjusts Price Target on Vaccitech to $14 From $15, Maintains Overweight Rating	18/08/23	MT
Morgan Stanley Adjusts Price Target on Vaccitech to $15 From $16, Maintains Overweight Rating	16/05/23	MT
HC Wainwright Adjusts Price Target on Vaccitech to $15 From $20, Maintains Buy Rating	27/03/23	MT
Possibility of US Fed's Rate Hike Pause Supports American Depositary Receipts of European Equities	23/03/23	MT
Morgan Stanley Adjusts Price Target on Vaccitech to $16 From $19, Maintains Overweight Rating	15/08/22	MT
HC Wainwright Adjusts Vaccitech's Price Target to $20 From $22, Keeps Buy Rating	11/08/22	MT
Morgan Stanley Trims Vaccitech's Price Target to $19 From $20, Maintains Overweight Rating	17/05/22	MT
HC Wainwright Adjusts Price Target on Vaccitech to $23 From $25, Maintains Buy Rating	15/12/21	MT
VACCITECH : Barclays Initiates Coverage on Vaccitech With Overweight Rating, $23 Price Target	25/05/21	MT
VACCITECH : William Blair Initiates Coverage on Vaccitech With Outperform Rating	25/05/21	MT
VACCITECH : Morgan Stanley Starts Vaccitech at Overweight With $22 Price Target	25/05/21	MT
VACCITECH : Jefferies Starts Vaccitech at Buy With $28 Price Target	25/05/21	MT
VACCITECH : HC Wainwright Starts Vaccitech at Buy With $25 Price Target	24/05/21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+201.5% on SUPER MICRO COMPUTER since our purchase on February 17, 2023

Replicate our performance

fermer